January’s Coding Challenge
The Rheumatologist: January 2009
January’s Coding Answer
Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.
Many people shy away from participating in advocacy efforts because they are uncomfortable with the terminology used.
Patient Fact Sheet
As the newly minted president of the ARHP, I’d like to introduce myself.
It is often a challenge for practices to keep up with all the coding changes that happen each year, and that’s why your ACR coding specialists are here.
F or the first time during its unprecedented initiative to find a cure for rheumatoid arthritis (RA), the ACR Research and Education Foundation (REF) is releasing new information acquired from research funded by the Within Our Reach campaign.
Does your staff know what is involved in taking a complete history from a patient?
The fortunes of industry and academia may rise and fall together
Annual Scientific Meeting no longer an endurance sport
Injury prevention and management in young athletes can arrest long-term harm
Information on safety, labeling changes, and pharmaceutical research
Common factors in arthritis patients increase falls risk